This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine. If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis of the CHMP recommendations, read the scientific discussion (also part of the EPAR).
Therapeutic Indication
### Therapeutic indication Imiquimod cream is indicated for the topical treatment of : - External genital and perianal warts (condylomata acuminata) in adults. - Small superficial basal cell carcinomas (sBCCs) in adults. - Clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (AKs) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.
Therapeutic Area (MeSH)
ATC Code
D06BB10
ATC Item
imiquimod
Pharmacotherapeutic Group
Antibiotics and chemotherapeutics for dermatological use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| imiquimod | N/A | 咪喹莫特 |
EMA Name
Aldara
Medicine Name
Aldara
Aliases
N/ANo risk management plan link.
